科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Proceedings of the National Academy of Sciences2026-01-02· Immune system

L-lactic acid enhances type I interferon immune response and inhibits virus infection by promoting IRF9 L-lactylation

Ying Miao, Qi Cui, Tingting Zhang, Renxia Zhang, Qian Zhao, Haiyan Zhou, Y. Zuo, Qin Wang, Yuerong Zhang, Zhijin Zheng, Wei He, Chunyan Liu, Yukang Yuan, Hui Zheng

原始摘要(英文原文)· Original abstract
Lysine lactylation is a crucial posttranslational modification (PTM) that regulates protein function. Here, this study revealed that L-lactic acid promotes host immune response and inhibits viral infection by inducing Interferon Regulatory Factor 9 (IRF9) L-lactylation. We first found L-lactylation modification (L-Kla) of IRF9 mediated by AARS1. Further studies demonstrated that IRF9 L-lactylation potentiates type I interferon (IFN-I) signaling by promoting IRF9-STAT2 interaction, thereby boosting antiviral immune response. Intriguingly, L-lactic acid exhibits dual effects on viral infection: L-lactic acid exhibits antiviral effects at physiological and moderately elevated levels but proviral effects at high levels. Furthermore, we found that the viruses can achieve immune evasion by promoting SIRT1-mediated delactylation of IRF9. Interestingly, we uncovered that metformin promotes IRF9 L-lactylation by both accumulating lactic acid and disrupting virus-induced IRF9-SIRT1 interaction. These findings renew the understanding of the roles of lactic acid in antiviral immune response and determine metformin's immunomodulatory effects on antiviral immunity through regulating IRF9 L-lactylation.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

L-lactic acid enhances type I interferon immune response and inhibits virus infection by promoting IRF9 L-lactylation — 科研速览 Science Skim